Basic research on molecular target therapy with radiotherapy for pancreatic cancer

Research Project

Project/Area Number	23791447
Research Category	Grant-in-Aid for Young Scientists (B)
Allocation Type	Multi-year Fund
Research Field	Radiation science
Research Institution	Keio University
Principal Investigator	SEKI Satoshi 慶應義塾大学, 医学部, 助教 (30398614)
Project Period (FY)	2011 – 2012
Project Status	Completed (Fiscal Year 2012)
Budget Amount *help	¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000) Fiscal Year 2012: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000) Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywords	分子標的薬 / 放射線 / 放射線併用法 / 膵臓臓癌 / 膵癌 / 分子標的治療 / HER2 / VEGF
Research Abstract	The molecular target drug, anti-EGFR antibody, is already used for the HER2 expression breast cancer in clinical. An effect of this drug is expected in pancreatic cancer and is in a clinical trial. Although there was few reports to study it's affect of co

Report

(3 results)